Bangladesh has recorded 418 dengue deaths and more than 133,000 hospital admissions since the start of 2026, according to health ministry figures covering the period through 30 October. October alone accounted for 173 of those deaths, up from 148 in September, making it the deadliest month for the disease this year, Al-Consolto reports, citing Reuters.
The figures point to a sustained outbreak that is still accelerating rather than easing, and they come as Bangladesh's hospitals are also handling a severe measles epidemic described in reports as the worst in the world, with more than 1,200 deaths.
Why it matters
Dengue is a mosquito-borne viral illness that spreads through the bite of infected Aedes mosquitoes, particularly Aedes aegypti. It does not usually pass directly from person to person through everyday contact. Because the virus has four main serotypes, a person can be infected more than once, and a prior infection with one type does not give lasting protection against the others.
That matters in Bangladesh right now. Experts quoted in the reporting warn that all four serotypes are circulating in the country, which raises the likelihood of repeat infections and of serious complications. According to WebMD, a second infection with a different serotype can carry a higher risk of progressing to severe disease, and researchers are still studying how the immune response to a first infection may contribute to that severity.
The pressure on the health system is visible at the hospital level. Doctors at Dhaka's state-run Shaheed Suhrawardy Medical College Hospital told Reuters that many dengue patients only seek care after their condition has already worsened and dangerous complications have set in. The hospital was treating 279 dengue patients after admitting 67 new cases in a single day, according to the report.
Some patients arrive in circulatory shock with sharply lowered blood pressure and falling oxygen levels, requiring emergency intervention, the doctors said. Delayed diagnosis and delayed treatment, along with repeat infection, are identified by experts as key factors behind the higher rates of complications and death.
Symptoms, warning signs and treatment
According to Medical News Today, some people infected with dengue show no symptoms at all, while others develop flu-like illness ranging from mild to moderate. Symptoms typically begin four to 10 days after the bite of an infected mosquito and can last between two and seven days. Because they resemble other viral illnesses, they cannot confirm dengue on their own, and blood tests may be needed.
WebMD notes that some cases develop into severe dengue, which affects blood vessels and circulation and can cause bleeding, shock or damage to organs. Danger signs can appear after a fever subsides, so a drop in temperature does not necessarily mean the patient is recovering. Severe dengue can progress quickly and become life-threatening, which is why such signs call for immediate hospital care.
Healthline reports that no approved antiviral drug treats dengue directly. Medical care focuses on relieving symptoms, maintaining fluid balance and monitoring for warning signs. Doctors caution against aspirin or ibuprofen when dengue is suspected, since those medicines can raise the risk of bleeding. Severe cases may require hospital admission, intravenous fluids and continuous medical supervision, with complications treated according to each patient's condition.
Prevention, according to WebMD, rests mainly on avoiding mosquito bites and reducing breeding sites, especially stagnant water collected in and around homes. The Aedes mosquitoes that carry dengue are notably active during daylight hours, particularly in the early morning and before sunset, so protection is needed outside sleeping hours as well.
What to watch
Entomologists warned Reuters that dengue transmission in Bangladesh is likely to continue through November, although the pace of deaths is expected to ease compared with October's levels. A meaningful improvement in the outbreak is not anticipated before December.
